NCT04891198 2026-03-25ENVAFOLIMAB Single-agent Treatment in Patients With Advanced Solid Tumors3D MedicinesPhase 2 Recruiting126 enrolled
NCT07260305 2025-12-03A Phase I Study to Investigate the Safety and Tolerability of KGX101 Monotherapy and Combination Therapy With Envafolimab in Advanced or Metastatic Solid Tumor PatientsKangabio AUSTRALIA LTD PTYPhase 1 Recruiting57 enrolled